Bevacizumab changes vascular structure and modulates the expression of angiogenic factors in recurrent malignant gliomas. [electronic resource]
Producer: 20161213Description: 129-36 p. digitalISSN:- 1861-387X
- Adult
- Becaplermin
- Bevacizumab -- pharmacology
- Brain Neoplasms -- blood supply
- Combined Modality Therapy
- Fatal Outcome
- Fibroblast Growth Factor 2 -- genetics
- Gene Expression -- drug effects
- Glioma -- blood supply
- Humans
- Male
- Middle Aged
- Molecular Targeted Therapy
- Neoplasm Recurrence, Local
- Proto-Oncogene Proteins c-sis -- genetics
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- genetics
- Vascular Endothelial Growth Factor Receptor-1 -- genetics
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.